Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period (original) (raw)
Michitaka K, Nishiguchi S, Aoyagi Y, Hiasa Y, Tokumoto Y, Onji M, et al. Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol. 2010;45:86–94. ArticlePubMed Google Scholar
Kawada N, Imanaka K, Kawaguchi T, Tamai C, Ishihara R, Matsunaga T, et al. Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis. J Gastroenterol. 2009;44:1190–4. ArticlePubMed Google Scholar
Amarapurkar DN, Hashimoto E, Laurentius LA, Sollano JD, Chen PJ, Goh KL, Asia-Pacific Working Party on NAFLD. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol. 2007;22:788–93. ArticlePubMed Google Scholar
Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci. 2010;55:560–78. ArticlePubMed Google Scholar
Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat percent relationship. Obes Rev. 2002;3:141–6. ArticlePubMedCAS Google Scholar
Hsieh SD, Yoshinaga H, Muto T, Sakurai Y, Kosaka K. Health risks among Japanese men with moderate body mass index. Int J Obes Relat Metab Disord. 2000;24:358–62. ArticlePubMedCAS Google Scholar
Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol. 2003;38:954–61. ArticlePubMed Google Scholar
Radu C, Grigorescu M, Crisan D, Lupsor M, Constantin D, Dina L. Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients. J Gastrointestin Liver Dis. 2008;17:255–60. PubMed Google Scholar
Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y, et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabetic Med. 2005;22:1141–5. ArticlePubMedCAS Google Scholar
Ezzati M, Lopez AD. Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control. 2004;13:388–95. ArticlePubMedCAS Google Scholar
Inoue M, Hanaoka T, Sasazuki S, Sobue T, Tsugane S. JPHC Study Group Impact of tobacco smoking on subsequent cancer risk among middle-aged Japanese men and women: data from a large-scale population-based cohort study in Japan—the JPHC study. Prev Med. 2004;38:516–22. ArticlePubMed Google Scholar
Hudson NL, Mannino DM. Tobacco use: a chronic illness? J Community Health. 2010;35:549–53. ArticlePubMed Google Scholar
Wada T, Urashima M, Fukumoto T. Risk of metabolic syndrome persists twenty years after the cessation of smoking. Intern Med. 2007;46:1079–82. ArticlePubMed Google Scholar
Fagard RH, Nilsson PM. Smoking and diabetes—the double health hazard! Prim Care Diabetes. 2009;3:205–9. Google Scholar
Attvall S, Fowelin J, Lager I, Von Schenck H, Smith U. Smoking induces insulin resistance—a potential link with the insulin resistance syndrome. J Intern Med. 1993;233:327–32. ArticlePubMedCAS Google Scholar
Will JC, Galuska DA, Ford ES, Mokdad A, Calle EE. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int J Epidemiol. 2001;30:540–6. ArticlePubMedCAS Google Scholar
Yeh HC, Duncan BB, Schmidt MI, Wang NY, Brancati FL. Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med. 2010;152:10–7. PubMed Google Scholar
Campbell Chelland S, Moffatt RJ, Stamford BA. Smoking and smoking cessation—the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis. 2008;201:225–35. Article Google Scholar
Hamaguchi M, Kojima T, Takebe N, Nakagawa T, Taniguchi H, Fujii K, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005;143:722–8. PubMedCAS Google Scholar
Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, et al. Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population. Am J Gastroenterol. 2009;104:2189–95. ArticlePubMed Google Scholar
Japanese Society of Internal Medicine. Definition criteria of the metabolic syndrome for Japanese population. J Jpn Soc Int Med. 2005;94:188–203. Google Scholar
World Health Organization Western Pacific Region, International Association for the Study of Obesity/International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Melbourne: Health Communications Australia; 2000.
Bataller R. Time to ban smoking in patients with chronic liver disease. Hepatology. 2006;44:1394–6. ArticlePubMed Google Scholar
El-Zayadi AR. Heavy smoking and the liver. World J Gastroenterol. 2006;12:6098–101. PubMedCAS Google Scholar
Zein CO. Clearing the smoke in chronic liver diseases. Hepatology. 2010;51:1487–90. ArticlePubMed Google Scholar
Suzuki A, Lindor K, Saver J, Lymp J, Mendes F, Muto A, et al. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatology. 2005;43:1060–6. ArticleCAS Google Scholar
Chavez-Tapia NC, Lizardi-Cervera J, Perez-Bautista O, Ramos-Ostos MH, Uribe M. Smoking is not associated with nonalcoholic fatty liver disease. World J Gastroenterol. 2006;12:5196–200. PubMedCAS Google Scholar
Husain K, Scott BR, Reddy SK, Somani SM. Chronic ethanol and nicotine interaction on rat tissue antioxidant defense system. Alcohol. 2001;25:89–97. ArticlePubMedCAS Google Scholar
Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr. 2008;87:801–9. PubMedCAS Google Scholar
Iwashima Y, Katsuya T, Ishikawa K, Kida I, Ohishi M, Horio T, et al. Association of hypoadiponectinemia with smoking habit in men. Hypertension. 2005;45:1094–100. ArticlePubMedCAS Google Scholar
Kawamoto R, Tabara Y, Kohara K, Miki T, Ohtsuka N, Kusunoki T, et al. Smoking status is associated with serum high molecular adiponectin levels in community-dwelling Japanese men. J Atheroscler Thromb. 2010;17:423–30. ArticlePubMedCAS Google Scholar
Agarwal R. Smoking, oxidative stress and inflammation: impact on resting energy expenditure in diabetic nephropathy. BCM Nephrol. 2005;6:13. Article Google Scholar
Avti PK, Kumar S, Pathak CM, Vaiphei K, Khanduja KL. Smokeless tobacco impairs the antioxidant defense in liver, lung, and kidney of rats. Toxicol Sci. 2006;89:547–53. ArticlePubMedCAS Google Scholar
Muriel P. Role of free radicals in liver diseases. Hepatol Int. 2009;3:526–36. Article Google Scholar
Yuan H, Shyy JYJ, Mokdad A. Second hand smoke stiulates lipid accumulation in the liver by modulating AMPK and SREBP-1. J Hepatol. 2009;51:535–47. ArticlePubMedCAS Google Scholar
El-Zayadi AR, Selim O, Hamdy H, El-Tawil A, Moustafa H. Heavy cigarette smoking induces hypoxic polycythemia (erythrocytosis) and hyperuricemia in chronic hepatitis C patients with reversal of clinical symptoms and laboratory parameters with therapeutic phlebotomy. Am J Gastroenterol. 2002;97:1264–5. ArticlePubMed Google Scholar
Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001;120:1183–92. ArticlePubMedCAS Google Scholar
Azzalini L, Ferrer E, Ramalho LN, Moreno M, Domínguez M, Colmenero J, et al. Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. Hepatology. 2010;51:1567–76. ArticlePubMedCAS Google Scholar
Zeidel A, Beilin B, Yardeni I, Mayburd E, Smirnov G, Bessler H. Immune response in asymptomatic smokers. Acta Anaesthesiol Scand. 2002;46:959–64. ArticlePubMedCAS Google Scholar
Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun. 2010;34:258–65. Article Google Scholar
Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med. 1988;27:142–9. PubMedCAS Google Scholar
Anezaki Y, Ohshima S, Ishii H, Kinoshita N, Dohmen T, Kataoka E, et al. Sex difference in the liver of hepatocyte-specific Pten-deficient mice: a model of nonalcoholic steatohepatitis. Hepatol Res. 2009;39:609–18. ArticlePubMedCAS Google Scholar
Suzuki A, Manal FA. Nonalcoholic fatty liver disease in women. Women’s Health. 2009;5:191–203. PubMed Google Scholar
Manjer J, Johansson R, Lenner P. Smoking as a determinant for plasma levels of testosterone, androstenedione, and DHEAs in postmenopausal women. Eur J Epidemiol. 2005;20:331–7. ArticlePubMedCAS Google Scholar
Economou F, Xyrafis X, Livadas S, Androulakis II, Argyrakopoulou G, Christakou CD, et al. In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls. Hormones (Athens). 2009;8:199–206. Google Scholar
John BD, Bhathal PS, Hughes NR, O’Brien PE. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology. 2004;39:1647–54. Article Google Scholar
Oza N, Eguchi Y, Mizuta T, Ishibashi E, Kitajima Y, Horie H, et al. A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff. J Gastroenterol. 2009;44:1203–8. ArticlePubMed Google Scholar
Hiramine Y, Imamura Y, Uto H, Koriyama C, Horiuchi M, Oketani M, et al. Alcohol drinking patterns and the risk of fatty liver in Japanese men. J Gastroenterol. doi:10.1007/s00535-010-0336-z.
Bailey SM, Mantena SK, Millender-Swain T, Cakir Y, Jhala NC, Chhieng D, et al. Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE(−/−) mouse: implications for a “multihit” hypothesis of fatty liver disease. Free Radic Biol Med. 2009;46:928–38. ArticlePubMedCAS Google Scholar